Corcept Therapeutics Incorporated shares owned by Louisiana State Employees Retirement System
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Louisiana State Employees Retirement System
from 13F filings
Historical chart of Louisiana State Employees Retirement System investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Louisiana State Employees Retirement System consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Louisiana State Employees Retirement System
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.1M | 45k | 46.28 |
| 2024-06-30 | $1.5M | 46k | 32.49 |
| 2024-03-31 | $1.1M | 45k | 25.19 |
| 2023-12-31 | $1.5M | 45k | 32.48 |
| 2023-09-30 | $1.3M | 46k | 27.25 |
| 2023-06-30 | $1.1M | 47k | 22.25 |
| 2023-03-31 | $968k | 45k | 21.66 |
| 2022-12-31 | $924k | 46k | 20.31 |
| 2022-09-30 | $1.2M | 46k | 25.65 |
| 2022-06-30 | $1.3M | 46k | 27.84 |
| 2022-03-31 | $1.1M | 46k | 22.98 |
| 2021-12-31 | $996k | 50k | 19.80 |
| 2021-09-30 | $990k | 50k | 19.68 |
| 2021-06-30 | $1.0M | 47k | 22.01 |
| 2021-03-31 | $1.1M | 48k | 23.79 |
| 2020-12-31 | $1.3M | 48k | 26.15 |
| 2020-09-30 | $837k | 48k | 17.40 |
| 2020-06-30 | $471k | 28k | 16.81 |
| 2020-03-31 | $338k | 28k | 11.89 |
| 2019-12-31 | $427k | 35k | 12.11 |
| 2019-09-30 | $534k | 38k | 14.13 |
| 2019-06-30 | $414k | 39k | 10.62 |
| 2019-03-31 | $458k | 39k | 11.74 |
| 2018-12-31 | $527k | 39k | 13.37 |
| 2018-09-30 | $653k | 47k | 14.01 |
| 2018-06-30 | $673k | 43k | 15.72 |
| 2018-03-31 | $696k | 42k | 16.45 |
| 2017-12-31 | $737k | 41k | 18.06 |
More positions owned by Louisiana State Employees Retirement System
View all positions for Louisiana State Employees Retirement System
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated